Search Results

You are looking at 1 - 10 of 2,290 items for :

Clear All
Full access

Heidi J. Gray

. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix . J Clin Oncol 2000 ; 18 : 1606 – 1613 . 13. Whitney CW

Full access

Robert W. Carlson, Elizabeth Brown, Harold J. Burstein, William J. Gradishar, Clifford A. Hudis, Charles Loprinzi, Eleftherios Paul Mamounas, Edith A. Perez, Kathleen Pritchard, Peter Ravdin, Abram Recht, George Somlo, Richard L. Theriault, Eric P. Winer, Antonio C. Wolff and for the NCCN Adjuvant Therapy for Breast Cancer Task Force

NCCN Adjuvant Therapy for Breast Cancer Task Force Members *Robert W. Carlson, MD / Chair#†  ¶¶ Stanford Hospital and Clinics Donald A. Berry, PhD††  The University of Texas M. D. Anderson Cancer Center *Elizabeth Brown, MD  National Comprehensive

Full access

F. Anthony Greco

. Folprecht G Seymour MT Saltz L . Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials . J Clin Oncol 2008 ; 26

Full access

Stephen G. Bown

“It is an ongoing struggle to establish photodynamic therapy [PDT] as a mainstream therapeutic option,” declared Stephen G. Bown, MD, FRCP, Director of the National Medical Laser Centre and Professor of Laser Medicine and Surgery at University

Full access

Elizabeth R. Plimack and Gary R. Hudes

.medscape.org/journal/jnccn ; (4) view/print certificate. Learning Objectives Upon completion of this activity, participants will be able to: Describe currently available and new agents (approved in the past 5 years) for the treatment of RCC Describe first-line therapy of

Full access

Patrick Ross Jr

“Photodynamic therapy (PDT) is not just a palliative treatment,” declared Patrick Ross, Jr, MD, PhD, Director, Division of Thoracic Surgery, The Ohio State University (OSU), Columbus, Ohio. “The real bang for the buck with PDT has got to be

Full access

Francisco Civantos

, these mainstream approaches may be associated with considerable complications. 1 Therefore, novel effective alternatives that reduce long-term morbidity without compromising future treatment options, such as photodynamic therapy (PDT), may play an

Full access

Carrie Zornosa, Jonathan L. Vandergrift, Gregory P. Kalemkerian, David S. Ettinger, Michael S. Rabin, Mary Reid, Gregory A. Otterson, Marianna Koczywas, Thomas A. D'Amico, Joyce C. Niland, Rizvan Mamet and Katherine M. Pisters

, selection of first-line therapy is a critical decision point in the treatment of advanced lung cancer. The oncology provider must balance toxicity, expected survival benefit, and impact on quality of life. The NCCN Clinical Practice Guidelines in Oncology

Full access

Harubumi Kato

Medical University, Japan. As a thoracic surgeon with more than 30 years of experience in photodynamic medicine, he believes that early-stage lung tumors can be completely treated with local noninvasive endoscopic treatments such as photodynamic therapy

Full access

Jeffrey K. Belkora, David W. Hutton, Dan H. Moore and Laura A. Siminoff

P atients with breast cancer who are at relatively low risk for recurrence or mortality after local therapy (surgery with or without radiation) face a “grey zone” decision about whether to undergo adjuvant therapy. 1 The choice of therapy